Vectibix (Panitumumab 100 MG/5 mL Injection)

Brand Name: Vectibix
API: Panitumumab
Packaging: Single-dose Vials
Strength: Injection: 100 mg/5 mL (20 mg/mL)
Manufacturer: Dr Reddy’s Laboratories

Get Price

Description

Uses of Medicine: Panitumumab 100 mg/5 mL injection is an anticancer medication classified as an epidermal growth factor receptor (EGFR) inhibitor. This therapeutic drug is specifically used to treat metastatic colorectal cancer, which originates in the colon or rectum and subsequently spreads to other areas of the body.

Dosage & Side Effects:

The recommended dosage of Panitumumab injection for the treatment of metastatic colorectal cancer is 6 mg/kg administered as an intravenous (IV) infusion over 60 minutes every 14 days. If the patient’s body weight exceeds 100 kg, the infusion time may be extended up to 90 minutes. Panitumumab is indicated for use as monotherapy or in combination with other chemotherapeutic agents. Dose modifications or discontinuation may be necessary based on the occurrence of infusion-related reactions or dermatologic toxicities. Always consult with a healthcare provider (HCP) for personalized dosage recommendations and management during treatment.

The most common side effects of Panitumumab 100 mg/5 mL injection are skin rash, dry skin, itching, nail changes, diarrhea, fatigue, nausea, and low magnesium levels. These symptoms may vary in severity among patients.

Warning and Precautions

  • Panitumumab can cause life-threatening infusion-related reactions, including anaphylaxis. Patients must be monitored closely during the initial infusion and for at least two hours afterward. Premedication and slow infusion rates may help mitigate risks.
  • Treatment with Vectibix 100 mg/5 mL may lead to significant decreases in serum magnesium levels, potentially resulting in neuromuscular and cardiac complications. Regular monitoring of magnesium and other electrolyte levels is essential, with appropriate supplementation as needed.
  • Patients often experience severe skin reactions such as acneiform rash, dryness, and dermatitis. These skin toxicities should be proactively managed to prevent discomfort, infection, and possible interruptions in therapy.
  • Although rare, Panitumumab has been associated with fatal cardiac arrest. Patients with a history of heart disease should undergo thorough cardiac evaluation before and during treatment. Continuous cardiac monitoring may be necessary for those at risk.
  • Treatment with this therapeutic drug can cause ILD, which may be severe or fatal. Patients should be monitored for new or worsening respiratory symptoms, such as cough or shortness of breath. Treatment should be discontinued if ILD is suspected.
  • Beyond hypomagnesemia, Panitumumab 100 mg/5 mL can cause other electrolyte disturbances. Regular blood tests should be conducted to monitor electrolyte levels, ensuring timely identification and correction of any imbalances.

FAQ's

What is the active substance in Vectibix?

Panitumumab is the active substance in Vectibix.

How is Panitumumab supplied?

This therapeutic drug is supplied in Injection: 100 mg/5 mL (20 mg/mL) in single-dose vials. Each vial contains 100 mg of Panitumumab in 5 mL (20 mg/mL) for intravenous infusion.

Who has introduced the generic version of Panitumumab in India?

Dr Reddy’s Laboratories has introduced a generic version of Panitumumab in India under the brand Vectibix. This new formulation of Panitumumab represents a significant advancement in the treatment options for metastatic colorectal cancer (mCRC) in the country.

How much does Panitumumab 100 mg/5 mL cost?

Please Call/WhatsApp: +91 8130290915 or dial our TOLL-FREE Number: 1800-889-1064 to know the exact Panitumumab cost in India. If you want to buy Panitumumab online, then THE INDIAN PHARMA (TIP) can help you access this medicinal product at the most competitive price through legal channels.

Is Panitumumab 100 mg/5 mL available in India?

Panitumumab is a pharmaceutical prescription medicinal product that can only be dispensed against a valid prescription from a treating physician. THE INDIAN PHARMA (TIP) can facilitate the supply of this drug to all locations after fulfilling the legal requirements (if applicable). Please contact us at +91 8130290915 | TOLL-FREE: 1800-889-1064 or at info@theindianpharma.com to buy Panitumumab from India at the best price.

Can I get Panitumumab injections even if I am not based in India?

THE INDIAN PHARMA (TIP) helps patients access Panitumumab, which is not approved in their home country, against a valid prescription and in conformity with their respective country’s local laws and regulations.

Send your inquiry to find generic Panitumumab in UAE, Iraq, Iran, Argentina, Brazil, Chile, Colombia, Peru, Saudi Arabia, Jordan, Mexico, Venezuela, Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Sri Lanka, Afghanistan, Poland, Slovakia, Armenia, Kazakhstan, Germany, Azerbaijan, Latvia, Moldova, the Philippines, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe, Australia, New Zealand, China, Cambodia, Indonesia, Malaysia, Singapore, Thailand, Vietnam, Kenya, Morocco, Hong Kong.

Where can I get the best Panitumumab Cost Price in India?

Panitumumab 100 mg/5 mL price is low and reasonable in India in comparison to other countries. If you wish to buy Panitumumab injections online from India at an affordable price, contact us today. We will help facilitate the supply of this therapeutic drug at the lowest possible prices.

Is it safe to buy Panitumumab online from India?

Yes, one can buy generic Panitumumab online at the best price from THE INDIAN PHARMA (TIP) if this medicine is not registered or is unavailable in their country. TIP can help facilitate the supply/export of Panitumumab injections through legal channels.

× How can I Help you?